In radioiodine therapy for malignant thyroid disease, the pre-therapeutically administered iodine-131-dose can reduce the potential of thyroid or thyroid carcinoma cells to absorb the following therapeutic iodine-131-dose, possibly leading to its failure...
Keywords: Radioiodtherapie, Stunning, Iod-123-Szintigraphie
01/2003 | Nuklearmedizin, Schattauer